Veracyte reported $-16681000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acceleron Pharma XLRN:US $ -70.63M 6.97M
Agilent A:US $ 395M 59M
Anika Therapeutics ANIK:US $ 1.3M 7.88M
Arrowhead Research ARWR:US $ -64883000 33.02M
Biocept BIOC:US $ 0.5M 2.25M
Bruker BRKR:US $ 113.2M 27.6M
Dicerna Pharmaceuticals DRNA:US $ -20.27M 19.97M
Exact Sciences EXAS:US $ -162.02M 9.64M
Genmark Diagnostics GNMK:US $ -2.09M 0.82M
Heron Therapeutics HRTX:US $ -51.71M 8.76M
Illumina ILMN:US $ -545000000 732M
Immunogen IMGN:US $ -34.23M 6.86M
Intrexon XON:US $ -25.47M 9.8M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Laboratory Of America LH:US $ 766.9M 67.8M
Ligand Pharmaceuticals LGND:US $ 15.61M 27.83M
Luminex LMNX:US $ 13.46M 2.96M
Myriad Genetics MYGN:US $ -79.9M 59.1M
Rigel Pharmaceuticals RIGL:US $ -19.78M 6.74M
Sangamo Biosciences SGMO:US $ -48.44M 0.26M
Siemens SIE:GR 1.62B 38M
Sonic Healthcare SHL:AU $ 925.75M 69.61M
Thermo Fisher Scientific TMO:US $ 2278M 115M
Veracyte VCYT:US $ -16.68M 9.21M
Waters WAT:US $ 191.82M 4.61M